Developer of a healthcare device designed to reduce sympathetic nerve activity and address the root cause of heart failure. The company's device allows clinicians to ablate the right greater splanchni...

Healthcare
New York, NY, United States
Founded 2014
20 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$75.8M
Last Round
N/A

Get the full picture

Create a free account to unlock Axon Therapies's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required